Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Zuclopenthixol hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zuclopenthixol 10mg tablets
0402010T0AAABAB
|
Zuclopenthixol hydrochloride | Zuclopenthixol hydrochloride | Central Nervous System | 17,567 |
|
Zuclopenthixol 2mg tablets
0402010T0AAAAAA
|
Zuclopenthixol hydrochloride | Zuclopenthixol hydrochloride | Central Nervous System | 6,476 |
|
Zuclopenthixol 25mg tablets
0402010T0AAACAC
|
Zuclopenthixol hydrochloride | Zuclopenthixol hydrochloride | Central Nervous System | 3,836 |
|
Clopixol 10mg tablets
0402010T0BBABAB
|
Clopixol (Systemic) | Zuclopenthixol hydrochloride | Central Nervous System | 3,508 |
|
Clopixol 2mg tablets
0402010T0BBAAAA
|
Clopixol (Systemic) | Zuclopenthixol hydrochloride | Central Nervous System | 1,930 |
|
Clopixol 25mg tablets
0402010T0BBACAC
|
Clopixol (Systemic) | Zuclopenthixol hydrochloride | Central Nervous System | 811 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.